• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Our Thanks to Reviewers in 2010

Article

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

And it is why all articles we publish must survive peer review not only by the distinguished leaders in primary care who make up our editorial board but also by several specialists and primary care physicians culled from Consultant readers. We ask reviewers to consider whether the discussion is accurate, balanced, complete, and timely; the drug regimens are reasonable; controversies are fairly outlined; the clinical advice is clear; and the recommended diagnostic and therapeutic measures are widely available in the community.

The questions these reviewers pose help the authors and staff keep Consultant squarely focused on your educational needs.

In this, the last issue of our 50th year of publication, we want to extend our thanks to the following reviewers who appraised at least one manuscript for us in 2010.

Navin M. Amin, MD Sandra L. Argenio, MD Richard Balon, MD Kirk Barber, MD J. David Beckham, MD Gerald Bernstein, MD Henry R. Black, MD Robert P. Blereau, MD William J. Brady, MD Charles S. Bryan, MD R. Michael Buckley, MD Lee S. Caplan, MD, PhD Roberto Cardarelli, DO, MPH Mercedes R. Carnethon, PhD Michael B. Chancellor, MD Rachmel Cherner, MD John F. Connolly, MD Mary E. Costanza, MD David Effron, MD S. Ather Enam, MD, PhD Richard G. Farmer, MD Faith T. Fitzgerald, MD Peter Frank, DO David R. Garr, MD Paul Gleich, MD Ladan Golestaneh, MD Caron M. Grin, MD Michael E. Hagensee, MD, PhD Gregory S. Harmon, MD Richard Harrigan, MD Warren A. Heffron, MD Jorge L. Herrera, MD Russell J. Hopp, DO Grace Brooke Huffman, MD Ben Huneycutt, MD Steve Iliffe, FRCGP Jonathan S. Ilowite, MD Mohit Jain, MD Kenar D. Jhaveri, MD Melissa Jones, PharmD Deepak M. Kamat, MD, PhD David L. Kaplan, MD Lawrence I. Kaplan, MD Jeffrey T. Kirchner, MD Harvey M. Kramer, MD Robert E. Leach, MD Edgar V. Lerma, MD Alexander K. C. Leung, MD Joseph A. Lieberman III, MD, MPH Richard Y. McConnell, MD Eugene Mochan, PhD, DO
Prashanth R. Mopala, MD John Mosby, MD Dale P. Murphy, MD Anita Nelson, MD David B. Nash, MD, MBA David T. Nash, MD Morris Papernik, MD Jacqueline G. Parthemore, MD Thomas L. Petty, MD Michael F. Picco, MD, PhD Susan M. Pollart, MD, MS D. Brady Pregerson, MD L. Michael Prisant, MD Robert E. Rakel, MD Sujatha Ramesh, MD Robert E. Reisman, MD Wayne Reynolds, DO Dale Rice, MD Diana Rinkevich, MD Robert J. Rogers, MD, FACP Ted Rosen, MD Marti Jill Rothe, MD Ronald N. Rubin, MD Gary E. Ruoff, MD Gregory W. Rutecki, MD Joseph D. Schmidt, MD Robert T. Segraves, MD, PhD Timothy H. Self, PharmD Edward J. Shahady, MD Leonid Skorin Jr, DO Clark Smith, MD Christopher Snell, PhD Andr N. Sofair, MD Todd P. Stitik, MD Michael B. Strauss, MD Stephen B. Sulavik, MD Nicole Touchet, MD Edward L. Trimble, MD Donald G. Vidt, MD Edward M. Weaver, MD, MPH Michael H. Weisman, MD Stuart Weiss, MD Herbert White, MD, MPH Russell D. White, MD James T. Willerson, MD Robert J. Wolfson, MD William Yaakob, MD Barbara P. Yawn, MD Durgamani K. Yellumahanthi, MD Richard J. Zimmer, DO
Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Tsuboya

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

Sydney Jennings
October 24th 2024
Article

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

CDC ACIP Meeting October 23-24: Day 1 Recap for Vaccines / image credit CDC logo ©Tada Images/stock.adobe.com

CDC ACIP Meeting October 23-24: Day 1 Recap for Vaccines

Sophie Abene
October 24th 2024
Article

The ACIP voted on recommendations for monovalent SARS-CoV-2 vaccine booster shots, lowering the age for pneumonia vaccination, and next steps for clesrovimab for RSV.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

New Data on Renal Protective Benefits of Sotagliflozin Will be Presented at Kidney Week 2024 / Image credit: ©Rasi/AdobeStock

New Data on Renal Protective Benefits of Sotagliflozin Will be Presented at Kidney Week 2024

Sydney Jennings
October 23rd 2024
Article

In a post hoc analysis of the SCORED trial, investigators observed positive renal protection with sotagliflozin across a spectrum of baseline kidney function and glycemic control.

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

Grace Halsey
October 23rd 2024
Article

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

© 2024 MJH Life Sciences

All rights reserved.